SeaStar Medical is trading 6.09% down at $3.31, with the broader Nasdaq-led selloff appearing to be the strongest available explanation amid elevated Treasury yields and persistent inflation concerns.
- On September 24, the company announced a University of Michigan innovation award for Dr. H. David Humes.
- The release contained no financial, clinical, or regulatory catalyst likely to explain the decline.